Enliven Therapeutics (ELVN) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.57
-0.53
-0.5
-0.46

Details

Expected EPS
-0.536822
Actual EPS
-0.49
Surprise EPS
0.05
Surprise Percent
+8.72%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.49 per share for Q3 2025.

0 Comments

Share your thoughts